(±)16(17)-DiHDPA – 1 mg

Brand:
Cayman
CAS:
1345275-27-5
Storage:
-20
UN-No:
Non-Hazardous - 1170 / 3

(±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid (DHA; Item No. 90310). It has been shown to inhibit VEGF-induced angiogenesis and reduce cancer cell metastasis in mice.{26641}  

 

Available on backorder

SKU: - Category:

Description

A DHA metabolite that inhibits VEGF-induced angiogenesis and reduces cancer cell metastasis in mice


Formal name: (±)16,17-dihydroxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid

Synonyms: 

Molecular weight: 362.5

CAS: 1345275-27-5

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Docosanoids||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways